Heart Disease News and Research

Latest Heart Disease News and Research

The gap in life expectancy between women and men is closing!

Women and men are living longer & staying more active. With fewer deaths from major causes such as heart disease and cancer Americans' are now on average living to a record 77.6 years.

1 Mar 2005

Aggressive industry promotion of prescription drugs may be a danger to patients and doctors

Vioxx, Celebrex and Bextra hit the market in the late 1990s & 2001, as a breakthrough class of drugs for arthritis that would help avoid ulcers and other digestive ailments linked to medicines such as aspirin.

28 Feb 2005

Intravenous vitamin D appears to significantly improve the survival of patients on dialysis

The administration of intravenous vitamin D appears to significantly improve the survival of patients on dialysis, according to a study that will be published in the April Journal of the American Society of Nephrology.

28 Feb 2005

Middle-aged women who take an active role in their health care may be less likely to develop cardiovascular disease

The results, presented today at the American Psychosomatic Society Annual Meeting, suggest women who believe they should take charge of their health, rather than rely solely on treatment by doctors, have fewer signs of pre-clinical atherosclerosis.

28 Feb 2005

First study to show cost-effectiveness of pre-diabetes intervention

More than 40 million Americans face a high risk of developing Type 2 diabetes, and it would cost a lot to give all of them intensive help with diet and exercise, or medication, to keep them from developing diabetes.

28 Feb 2005

Rising awareness, new product alternatives to boost prospects of European sleep apnea diagnostics market

Low levels of awareness among patients and physicians about sleep apnea are hindering the uptake of related diagnostics. Increased knowledge about this breathing disorder together with the emergence of new alternatives to current diagnostics tools is set to aid in market expansion.

28 Feb 2005

Mystery blood vessel disorder implicated in lacunar or "mini" strokes

Physicians have long been puzzled by a condition called intracranial arterial dolichoectasia, in which the larger arteries of the brain become elongated and misshapen.

28 Feb 2005

PET/CT imaging technology for cancer patients

Cancer patients at Mercy & Unity Hospitals have access to the latest in diagnostic imaging to assess the presence and extent of most types of cancer.

28 Feb 2005

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.

27 Feb 2005

Promising new strategy for Swedish medical research

Research scientists at Karolinska Institutet are planning an international initiative to map out the relationships between health, genes and lifestyle. Discussion partners include world-leading researchers from the USA, Britain, Singapore and Norway.

27 Feb 2005

Caution against FDA approval of race-based pharmaceutical

New York University Sociologist Troy Duster concludes that a pharmaceutical to combat heart disease among blacks is based on faulty research and urges the Food and Drug Administration to obtain more reliable data before approving the drug.

27 Feb 2005

Beginning of new wave - first generation to turn 18 since technology and treatments have allowed them to survive to adulthood

More than half a million children with special health-care needs will turn 18 this year, the first generation to reach adulthood since sweeping medical advances ensured an unprecedented number would survive congenital conditions that until recently would have killed them.

27 Feb 2005

Several causes for concern regarding children's health in general practice in Britain

An editorial in this weeks BMJ highlights several causes for concern regarding children's health in general practice in Britain. Once greatly admired, the British model of general practice raises concern over the future of children's health.

27 Feb 2005

Live surgical webcast of a minimally invasive mitral valve repair procedure

NYU Medical Center's Department of Cardiothoracic Surgery will conduct a live surgical webcast on March 9th at 3 pm ET of a minimally invasive mitral valve repair procedure.

27 Feb 2005

Genzyme begins gene transfer trial for peripheral arterial disease

Genzyme Corporation announced today that the first patient has been treated in a new phase 2 clinical trial examining the safety and effectiveness of locally delivered gene transfer for patients with peripheral arterial disease.

24 Feb 2005

Childhood obesity is a serious health problem in Australia

Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.

24 Feb 2005

Should screening for sleep apnea be required for all men?

According to a new study, men in their 20s need to be screened the most. That's because men aged 20 to 29 with severe sleep apnea have 10 times the risk of dying from heart related ailments than their non sleep apnea peers in the general population, and a much higher risk than older men with sleep apnea.

24 Feb 2005

Counseling smokers to quit reduced their chances of dying

Giving up smoking after a heart attack has been clearly associated with improvements in long-term patient survival, but how soon after myocardial infarction does smoking cessation begin to have positive effects?

24 Feb 2005

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.

23 Feb 2005

Taipan venom used as a new drug to treat heart failure

A venom component from the Taipan, the world’s deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.

23 Feb 2005